EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS012-21295 
Organism
Homo sapiens 
Tissue/cell
Caco-2 
Coordinate
chr7:2797430-2798430 
TF binding sites/motifs
Number: 6             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
FOSL1MA0477.1chr7:2797679-2797690GATGAGTCACT-6.02
JUN(var.2)MA0489.1chr7:2797680-2797694ATGAGTCACTCCCT-6.8
JUNDMA0491.1chr7:2797679-2797690GATGAGTCACT-6.32
Myod1MA0499.1chr7:2797718-2797731AGCAGCTGTTGCT+6.59
Nfe2l2MA0150.2chr7:2797707-2797722CAGGATGAGTCAGCA+7.05
Tcf12MA0521.1chr7:2797717-2797728CAGCAGCTGTT-6.32
Number of super-enhancer constituents: 5             
IDCoordinateTissue/cell
SE_09907chr7:2796403-2801305CD14
SE_37930chr7:2795837-2802684HSMMtube
SE_45906chr7:2796113-2804065Osteoblasts
SE_46833chr7:2797811-2798624Ovary
SE_65520chr7:2796017-2801146Pancreatic_islets
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr727974652798227
Enhancer Sequence
TAGTACGTAC TGAACGCTTG CTGAGTCAAT GAAGACATGT GTTTTTTCAA ACCTGACTTT 60
TTAAATGGCA GCTTAAATAT TTTTTCCTTT AATAGCTTAG TGGTTCTCTG ACTCCTGTTC 120
GCTGTCCCCA CATCAGAATA GCAATAATAA GGAATGATTC TTCCCTCCCC CTGCAAATGT 180
AGCTGCCTGG TTAACACAGA ACACAAGCTC TACAGACCTA ATAAATGTCT GGAAAACCTC 240
TTGCTTGGGG ATGAGTCACT CCCTAACTCA AAACCAACAG GATGAGTCAG CAGCTGTTGC 300
TTCAGGCTCT TTATGGAAAG CCCCTCTATT TTTACTATCC TATTCTTAAA CAAAGACAAA 360
AACCCAAAAA CTCAACATCT CCCCAACTAT CGATGCTTAC AGTATTAGAA ATGAAAACTC 420
AGAGCTTTTA AGAAAACAAG GCTTTAGGGC CGGGTGCAGT GGCTCACACT GTAATCCTAG 480
CACTTTAAGA AAACAAGGCT CTGCAAACAC TTATCTCATT CGCCATCCAA GTGATGACAT 540
CCTCATACGT CGTGTGGCCT CTGAAAAGCT CCAATGCAGG CTTGCACATG AAAGAGGGTG 600
TAAAGGGCAG ACAGTGTCTC AGCAGTTTCA TGTGTTCTGT GCTGTCAGGG TTCTAAGACG 660
AGCCTCAATG ACACACGCCC TGTGCAATTT CTTCCCCTGC AGCGTGGGAG GAAGCTGGAG 720
TGTGATGGAA CGTATCTCCT GTGATTGGGC GACTTTCAGC TAAGCCAAAG GGAGGTGATC 780
TTGGTGGGCC TGATCTAATC AGGGGAGCCT TTCAAGGAAC CTGGGGGAAC CCCTGAAAGG 840
GTCTCGGGGG CCCCCACAGC ACACTTGGAG GAACCCCTGT GCTAGAGAGG TTGGTGCCTG 900
TGTAGCAGCG TGCCCCTAAC AGCAGAGTCA CAGCCCTAGG CTGGAAGCCA CCAGTGCCCA 960
CCTCTGGTTC AGTGGATAAT CAAGTGCAGT TTACTCATCT 1000